nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—SLC6A4—Monoamine Transport—HRH3—narcolepsy	0.0367	0.0367	CbGpPWpGaD
Dexfenfluramine—HTR2B—Serotonin receptors—HTR2A—narcolepsy	0.0345	0.0345	CbGpPWpGaD
Dexfenfluramine—HTR2C—Serotonin receptors—HTR2A—narcolepsy	0.0278	0.0278	CbGpPWpGaD
Dexfenfluramine—HTR2B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0259	0.0259	CbGpPWpGaD
Dexfenfluramine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—narcolepsy	0.0229	0.0229	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HRH3—narcolepsy	0.0209	0.0209	CbGpPWpGaD
Dexfenfluramine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—narcolepsy	0.0185	0.0185	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—HCRTR2—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—HCRTR1—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Dexfenfluramine—HTR2B—Monoamine GPCRs—HTR2A—narcolepsy	0.0153	0.0153	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—P2RY11—narcolepsy	0.0136	0.0136	CbGpPWpGaD
Dexfenfluramine—HTR2B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0126	0.0126	CbGpPWpGaD
Dexfenfluramine—HTR2C—Monoamine GPCRs—HTR2A—narcolepsy	0.0124	0.0124	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0122	0.0122	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HCRT—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0114	0.0114	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—P2RY11—narcolepsy	0.011	0.011	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0109	0.0109	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Dexfenfluramine—HTR2C—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0102	0.0102	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00981	0.00981	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HCRT—narcolepsy	0.00933	0.00933	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.009	0.009	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00878	0.00878	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00878	0.00878	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—TRH—narcolepsy	0.00876	0.00876	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00856	0.00856	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00848	0.00848	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00834	0.00834	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Monoamine Transport—TNF—narcolepsy	0.00787	0.00787	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00783	0.00783	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00766	0.00766	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00752	0.00752	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00752	0.00752	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HCRTR2—narcolepsy	0.0071	0.0071	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HCRTR1—narcolepsy	0.0071	0.0071	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—TRH—narcolepsy	0.00707	0.00707	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—NPS—narcolepsy	0.00699	0.00699	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—P2RY11—narcolepsy	0.00686	0.00686	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00682	0.00682	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—NPS—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—TAC1—narcolepsy	0.00636	0.00636	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00632	0.00632	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00618	0.00618	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00594	0.00594	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HCRT—narcolepsy	0.00583	0.00583	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0058	0.0058	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HCRTR2—narcolepsy	0.00573	0.00573	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HCRTR1—narcolepsy	0.00573	0.00573	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00569	0.00569	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00569	0.00569	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—P2RY11—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0055	0.0055	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—PENK—narcolepsy	0.0052	0.0052	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00515	0.00515	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—TAC1—narcolepsy	0.00514	0.00514	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—NPS—narcolepsy	0.00514	0.00514	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00509	0.00509	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00479	0.00479	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HCRT—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00468	0.00468	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00459	0.00459	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00459	0.00459	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—TRH—narcolepsy	0.00442	0.00442	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00422	0.00422	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—PENK—narcolepsy	0.00419	0.00419	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0041	0.0041	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00401	0.00401	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00383	0.00383	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.00356	0.00356	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.00352	0.00352	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.00329	0.00329	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.00321	0.00321	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.00313	0.00313	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.00309	0.00309	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00296	0.00296	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00276	0.00276	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.00267	0.00267	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.00266	0.00266	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Dexfenfluramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00239	0.00239	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00231	0.00231	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CHKB—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.00208	0.00208	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.00199	0.00199	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.00177	0.00177	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CHKB—narcolepsy	0.00171	0.00171	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—P2RY11—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—NPS—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—TAC1—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRH3—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PENK—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00157	0.00157	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CPT1B—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—NPS—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HCRT—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TRH—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—NPS—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—TAC1—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CHKB—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CHKB—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CHKB—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRH3—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CPT1B—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CHKB—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	0.000991	0.000991	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NPS—narcolepsy	0.000973	0.000973	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TAC1—narcolepsy	0.000973	0.000973	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRH3—narcolepsy	0.000947	0.000947	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CPT1B—narcolepsy	0.000897	0.000897	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	0.00088	0.00088	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000825	0.000825	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000818	0.000818	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	0.0008	0.0008	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NPS—narcolepsy	0.000785	0.000785	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TAC1—narcolepsy	0.000785	0.000785	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000699	0.000699	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HTR2A—narcolepsy	0.000585	0.000585	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HTR2A—narcolepsy	0.000472	0.000472	CbGpPWpGaD
